Skip to main content
. 2013 Apr 19;3:94. doi: 10.3389/fonc.2013.00094

Table 1.

Patient characteristics.

n % Overall survival P
Patient numbers (1990–2010) 54
Patient numbers (1990–2000/2001–2010) 24/30 44/54 ns
Age (years) 6.5 ± 4.2
Age (<3/>3 years) 14/40 26/74 42 ± 1/53 ± 1 ns
Sex (male/female) 32/22 59/41 54 ± 1/43 ± 1 ns
Histology (classic/nodular/anaplastic) 39/11/2 74/22/4 46 ± 1/68 ± 1/50 ± 3 ns
Resection: CR/PR 25/28 47/53 62 ± 1/40 ± 1 0.05
Metastasis (no/yes) 34/16 68/32 56 ± 1/30 ± 1 0.05
Radiotherapy (yes/no) 40/9 82/18 60 ± 1/11 ± 1 0.000*
Relapse (yes/no) 18/31 37/63 13 ± 1/69 ± 1 0.001*
HDCT (yes/no) 15/31 33/67 29 ± 1/57 ± 1 ns
Status (CR/PR/dead) 22/4/22 46/8/46
Follow up (months) 60.0 ± 2.6
Survival (1990–2000/2001–2010) 50 ± 7 (52 ± 1/40 ± 1) ns

Data are expressed as mean ± SEM. NS: no significance; CR: complete remission, PR: partial remission; HDCT: high dose chemotherapy and autologous stem cell rescue.*Significance at multivariate analysis.